Discover 429 paid clinical trials in Colorado Springs, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 429
FeaturedActive & Responsive
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
for
Metastatic Colorectal Cancer
Location: Lone Tree CO, Aurora CO, Phoenix AZ, Denton TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT04929223
Phase 1, Recruiting
FeaturedActive & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Lone Tree CO, Littleton CO, Wichita KS, Norman OK,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase 3, Recruiting
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
for
Diabetes Mellitus, Type 2, Obesity
Location: Englewood CO, Albuquerque NM, West Jordan UT,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea
for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: Englewood CO, Albuquerque NM, West Jordan UT, Omaha NE,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Diabetic Nerve Pain Study of a Non-Opioid Medication for Adults With Ongoing Foot and Leg Pain
Location: Englewood CO, West Jordan UT, Norfolk NE, Lincoln NE,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
for
Sleep Apnea, Obstructive, Obesity, Overweight
Location: Aurora CO, Shreveport LA
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07369011
Phase 3, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Colorado Springs CO, Fort Collins CO, Farmington NM,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase 3, Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Colorado Springs CO, Lubbock TX, Glendale AZ,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819891
Phase 3, Recruiting
Featured
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
for
Crohn's Disease, Ulcerative Colitis
Location: Colorado Springs CO, Lubbock TX, Phoenix AZ,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07697456
Phase 2, Recruiting
Featured
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
for
Ulcerative Colitis
Location: Colorado Springs CO, Salt Lake City UT, Lancaster CA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT06979336
Phase 2, Recruiting
Featured
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
for
Primary Open Angle Glaucoma
Location: Colorado Springs CO, Aurora CO, Oklahoma City OK,
Sponsor: AbbVie
Sex: All
Age: 45+
Code: NCT06822738
Phase 3, Recruiting
Featured
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
for
Non Small Cell Lung Carcinoma, c-MET
Location: Lone Tree CO, Aurora CO, Salt Lake City UT, Lubbock TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06772623
Phase 1, Phase 2, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: Denver CO, West Valley City UT, Omaha NE,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07278336
Phase 1, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)